Search Results 661-670 of 16118 for Bacteriostatic

  1. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With ...

  2. Infectious Diseases - Mayo Clinic News Network

    Antimicrobial Awareness Week, Nov. 18–24, serves as a global call to action to address antimicrobial resistance (AMR) — a growing public health concern that ...

  3. Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission - Mayo Clinic

    Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. A Study of New Laboratory Assays to Develop Better Therapies for Treating Patients with Graves’ Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Halofantrine (oral route) - Side effects & dosage - Mayo Clinic

    Halofantrine belongs to a group of medicines known as antimalarials. It is used to treat malaria, a red blood cell infection transmitted by the bite of a ...

  7. Medical and Resource Facilitation Intervention After Traumatic Brain Injury (MRFI) - Mayo Clinic

    The purpose of this study is to determine if there are changes in mild traumatic brain injury (mTBI) and/or repetitive head impacts (RHI) detectible with ...

  8. Abrocitinib (oral route) - Side effects & dosage - Mayo Clinic

    Abrocitinib is used to treat moderate to severe atopic dermatitis (eczema) in patients who have taken other medicines that did not work well and whose condition ...

  9. Science Saturday: Sleuthing out the fingerprint of disease - Mayo Clinic News Network

    In the winter of 2014, staff of the Newborn Intensive Care Unit had a serious problem. Researchers at Mayo Clinic Hospital — Rochester, Saint Marys Campus ...

  10. A Study of Ramucirumab Plus Docetaxel in Patients With Urothelial Cancer - Mayo Clinic

    About this study. The main purpose of this study is to evaluate the safety and effectiveness of the study drug ramucirumab in combination with docetaxel in ...